Massachusetts General Hospital Department of Anesthesia, Critical Care and Pain Medicine - Faculty
Mass General Hospital  
 
 printemailA  |  A  |  A   
 

Browse our faculty by last name:

A - I   |   J - R   |   S - Z   |   All
 
 

Marcos F. Vidal-Melo, MD, PhD

Marcos F. Vidal-Melo, MD, PhD

Position

Director, Cardiac Anesthesia Research; Associate Professor, Harvard Medical School

Clinical Specialty

Cardiac Anesthesia, Pulmonary Pathophysiology, Inflammatory Response During Cardiac Surgery, Ventricular Assist Devices

Professional Activities

The Laboratory of Applied Biofluids/DACCPM/MGH is the site of most of our research. Our interest is centered in the application of bioengineering techniques to the study of the cardiopulmonary function. In recent years, our focus was the use of mathematical modeling and tracer kinetics analysis to the development of positron emission tomography (PET) techniques to study lung structure, function and inflammation.

Our current efforts are dedicated to two interconnected areas. The first, fundamentally bioengineering based, corresponds to the development of experimental and computational tools for the study of PET images. The second area of study is related to the application of the PET techniques to understand and optimize treatment of experimental and human cardiopulmonary disease.

Our results revealed, for the first time using imaging techniques, the bimodal ventilation-perfusion distributions that are predicted theoretically and obtained experimentally with a standard non-imaging technique (multiple inert gases, MIGET).

Recently, we started projects on Clinical Research in Cardiac Anesthesia. Investigations include:

a) pulmonary function after off-pump and on-pump coronary artery bypass surgery in moderate to severe obstructive pulmonary disease

b) neurocognitive dysfunction after cardiac surgery assessed with Positron Emission Tomography

c) mathematical modeling of the cardiovascular system using radial artery waveforms

d) a phase III drug study in patients with HIT/HITTS Type II undergoing off-pump coronary artery bypass (OPCAB) surgery

e) a multicenter, randomized, parallel-group, placebo-controlled study of 2mg/kg bolus plus 24-hour 0.05 mg/kg/hr infusion of Pexelizumab in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass

Medical Training

Federal Fluminense University, Brazil, MD
University of Heidelberg, PhD

Publications

View Publications

Contact Information

Department of Anesthesia, Critical Care and Pain Medicine
55 Fruit Street
Boston, MA 02114
Phone: 617-726-8980



 
Office Information

Department of Anesthesia,
Critical Care and Pain Medicine
Gray-Bigelow 444
55 Fruit Street
Boston, MA 02114

Public Transportation Access: Yes
Disabled Access: Yes